Nigerian drug-makers are currently in a growth phase as earnings surge on aggressive expansion, improved and innovative products, and health awareness among the citizenry. Data compiled by BusinessDay show that five quoted drug-makers recorded double-digit growth in revenues for 2013 as sales increa
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp